Cargando…

Epidemiology, Outcome and Risk Factors Analysis of Viral Infections in Children and Adolescents Undergoing Hematopoietic Cell Transplantation: Antiviral Drugs Do Not Prevent Epstein–Barr Virus Reactivation

OBJECTIVE: The analysis of epidemiology, risk factors and outcome of viral infections in children and adolescents after hematopoietic cell transplantation (HCT). METHODS: In this multicenter nationwide study a total of 971 HCT procedures (741 allo-HCT; 230 auto-HCT) over a period of 6 years were ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czyzewski, Krzysztof, Dziedzic, Magdalena, Salamonowicz, Malgorzata, Fraczkiewicz, Jowita, Zajac-Spychala, Olga, Zaucha-Prazmo, Agnieszka, Gozdzik, Jolanta, Galazka, Przemyslaw, Bartoszewicz, Natalia, Demidowicz, Ewa, Styczynski, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925545/ https://www.ncbi.nlm.nih.gov/pubmed/31908501 http://dx.doi.org/10.2147/IDR.S224291

Ejemplares similares

Analysis of incidence and risk factors of the multidrug resistant gastrointestinal tract infection in children and adolescents undergoing allogeneic and autologous hematopoietic cell transplantation: a nationwide study
por: Salamonowicz-Bodzioch, Małgorzata, et al.
Publicado: (2021)

Prospective analysis of BKV hemorrhagic cystitis in children and adolescents undergoing hematopoietic cell transplantation
por: Salamonowicz-Bodzioch, Małgorzata, et al.
Publicado: (2021)

Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study
por: Czyżewski, Krzysztof, et al.
Publicado: (2019)

Infectious complications in children with malignant bone tumors: a multicenter nationwide study
por: Czyzewski, Krzysztof, et al.
Publicado: (2019)

Risk Factors for Transplant Outcomes in Children and Adolescents with Non-Malignant Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Zaucha-Prażmo, Agnieszka, et al.
Publicado: (2019)

Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation
por: Salamonowicz, Małgorzata, et al.
Publicado: (2018)

Complex profile of multiple hepatobiliary and gastrointestinal complications after hematopoietic stem cell transplantation in a child with Nijmegen breakage syndrome
por: Gałązka, Przemysław, et al.
Publicado: (2019)

Impact of donor and recipient Epstein-Barr Virus serostatus on outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis
por: Kołodziejczak, Michalina, et al.
Publicado: (2021)

Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein–Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant
por: Diop, Ndeye Soukeyna, et al.
Publicado: (2021)

Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection
por: Grześk, Elżbieta, et al.
Publicado: (2022)

The Impact of High CMV Viral Load and Refractory CMV Infection on Pediatric HSCT Recipients with Underlying Non-Malignant Disorder
por: Szmit, Zofia, et al.
Publicado: (2022)

Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation
por: Wu, Xiu-li, et al.
Publicado: (2012)

EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOID MALIGNANCIES: THE EXPANDING SPECTRUM OF HEMATOPOIETIC NEOPLASMS
por: KIMURA, HIROSHI, et al.
Publicado: (2013)

Relapse/Refractory Paediatric B-ALL Case with CD19(−) Phenotype Switching Indicating the Importance of Appropriate Diagnostic Approach and Targeted Treatment Adjustment—Case Report
por: Prażmo, Anna, et al.
Publicado: (2023)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Strategies of Epstein-Barr virus to evade innate antiviral immunity of its human host
por: Albanese, Manuel, et al.
Publicado: (2022)

Short-term and mid-term effects of thoracoscopic repair of esophageal atresia: No anastomotic leaks or conversions to open technique
por: Galazka, Przemyslaw, et al.
Publicado: (2022)

Association of Epstein-Barr virus infection with allogeneic hematopoietic stem cell transplantation in patients in Portugal
por: Marinho-Dias, Joana, et al.
Publicado: (2019)

Association Between Cytomegalovirus and Epstein-Barr Virus Co-Reactivation and Hematopoietic Stem Cell Transplantation
por: Li, Shan-shan, et al.
Publicado: (2022)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Strategy of pre-emptive management of Epstein-Barr virus post-transplant lymphoproliferative disorder after stem cell transplantation: results of European transplant centers survey
por: Gil, Lidia, et al.
Publicado: (2012)

Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation
por: Feuillet, S., et al.
Publicado: (2009)

Diagnostic difficulties of AH1N1 influenza infection in children with acute lymphoblastic leukemia: Two case reports
por: Zawitkowska, Joanna, et al.
Publicado: (2020)

Blinatumomab Prior to CAR-T Cell Therapy—A Treatment Option Worth Consideration for High Disease Burden
por: Marschollek, Paweł, et al.
Publicado: (2022)

Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
por: Smith, Danielle Westhoff, et al.
Publicado: (2013)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Epstein-Barr virus protein BKRF4 restricts nucleosome assembly to suppress host antiviral responses
por: Chen, Jiao, et al.
Publicado: (2022)

Therapy results in pediatric Hodgkin lymphoma — does less mean better? Experience from a single children’s oncology center
por: Stankiewicz, Joanna, et al.
Publicado: (2023)

Epstein-Barr Virus and Human Cancer
por: Young, Lawrence
Publicado: (2002)

An Epstein-Barr virus-associated superantigen
Publicado: (1996)

Macular Amyloidosis and Epstein-Barr Virus
por: Nahidi, Yalda, et al.
Publicado: (2016)

Epstein-Barr virus infection mechanisms
por: Chesnokova, Liudmila S., et al.
Publicado: (2014)

Epstein-Barr Virus Neurologic Complications
por: Millichap, J. Gordon
Publicado: (2015)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Epstein-Barr virus and nasopharyngeal carcinoma
por: Young, Lawrence S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fhbqc6kaa2hd50iglbd7895rul